TDOC · Teladoc Health Inc. Common Stock
View on chartInsiders & Stakes
| Jason N. Gorevic Chief Executive Officer | ▼ Sell | Open Market | 653,073 Shares held | 3/4/2024 | View profile |
| Charles Divita III CHIEF EXECUTIVE OFFICER | ▼ Sell | Open Market | 465,535 Shares held | 9/11/2026 | View profile |
| Murthy Mala Director | ▼ Sell | Open Market | 142,385 Shares held | 9/2/2025 | View profile |
| Adam C. Vandervoort CHIEF LEGAL OFFICER, SECRETARY | ▼ Sell | Open Market | 117,616 Shares held | 9/2/2026 | View profile |
| David B. Snow Jr. Director | ▲ Buy | Option Exercise | 113,032 Shares held | 5/20/2026 | View profile |
| Kornwasser Laizer PRESIDENT, ENTERPRISE GROWTH | ▼ Sell | Open Market | 99,929 Shares held | 8/2/2024 | View profile |
| Kelly Bliss President, U.S. Group Health | ▼ Sell | Open Market | 92,832 Shares held | 9/2/2026 | View profile |
| Waters Michael Willem CHIEF OPERATING OFFICER | ▼ Sell | Open Market | 78,309 Shares held | 9/3/2024 | View profile |
| Nanis Nikolaos P. Chief Technology Officer | ▼ Sell | Open Market | 75,410 Shares held | 9/3/2024 | View profile |
| Catherine Jacobson Director | ▲ Buy | Option Exercise | 66,853 Shares held | 5/20/2026 | View profile |
| Carlos Nueno President, International | ▼ Sell | Open Market | 64,744 Shares held | 9/2/2026 | View profile |
| David L. Shedlarz Director | ▲ Buy | Option Exercise | 61,266 Shares held | 5/20/2026 | View profile |
| MCKINLEY THOMAS | ▲ Buy | Option Exercise | 56,544 Shares held | 5/21/2025 | View profile |
| Verstraete Stephany Chief Marketing Officer | ▼ Sell | Open Market | 48,843 Shares held | 9/3/2024 | View profile |
| Geshuri Arnnon Chief Human Resources Officer | ▼ Sell | Open Market | 44,914 Shares held | 9/3/2024 | View profile |
| Daniel Karen L Director | ▼ Sell | Open Market | 36,995 Shares held | 5/23/2024 | View profile |
| Raman-Tangella Vidya CHIEF MEDICAL OFFICER | ▼ Sell | Open Market | 33,665 Shares held | 9/4/2024 | View profile |
| Trencher Daniel SVP Corporate Strategy | ▼ Sell | Open Market | 31,465 Shares held | 9/3/2024 | View profile |
| Turitz Andrew SVP - BUSINESS DEVELOPMENT | ▼ Sell | Open Market | 20,773 Shares held | 9/4/2024 | View profile |
| Jensen Claus Torp CHIEF INNOVATION OFFICER | ▲ Buy | Option Exercise | 20,703 Shares held | 12/1/2023 | View profile |
| Napolitano Richard J Chief Accounting Officer | ▼ Sell | Open Market | 18,077 Shares held | 3/4/2024 | View profile |
| Joseph Ronald Catapano Chief Accounting Officer | ▼ Sell | Open Market | 14,293 Shares held | 10/2/2026 | View profile |
| Cave James L. INTERIM CAO | ▼ Sell | Open Market | 13,808 Shares held | 9/3/2024 | View profile |
| Frist William H. Director | ▲ Buy | Option Exercise | 12,918 Shares held | 9/15/2021 | View profile |
| Fenwick Sandra L Director | ▲ Buy | Option Exercise | 12,070 Shares held | 11/17/2023 | View profile |
| Kenneth H. Paulus Director | ▲ Buy | Open Market | 10,000 Shares held | 11/14/2025 | View profile |
| Jason Eric Evans Director | ▲ Buy | Option Exercise | 9,145 Shares held | 12/19/2025 | View profile |
| Mark Douglas Smith Director | ▲ Buy | Open Market | 8,355 Shares held | 8/15/2024 | View profile |
| Bischoff Christopher | ▲ Buy | Option Exercise | 7,195 Shares held | 5/17/2022 | View profile |
| Fernando M. Rodrigues President of BetterHelp | ▼ Sell | Open Market | 0 Shares held | 9/3/2026 | View profile |
Transaction History
| Joseph Ronald Catapano | ▼ Sell | Open Market | 655 | $4K | 10/2/2026 |
| Joseph Ronald Catapano | ▲ Buy | Option Exercise | 2,083 | — | 10/1/2026 |
| Charles Divita III | ▼ Sell | Open Market | 17,805 | $109K | 9/11/2026 |
| Charles Divita III | ▲ Buy | Option Exercise | 3,642 | — | 9/10/2026 |
| Charles Divita III | ▲ Buy | Option Exercise | 39,160 | — | 9/10/2026 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 9,812 | $64K | 9/3/2026 |
| Carlos Nueno | ▼ Sell | Open Market | 6,200 | $39K | 9/2/2026 |
| Kelly Bliss | ▼ Sell | Open Market | 7,357 | $46K | 9/2/2026 |
| Joseph Ronald Catapano | ▼ Sell | Open Market | 274 | $2K | 9/2/2026 |
| Charles Divita III | ▼ Sell | Open Market | 18,327 | $115K | 9/2/2026 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 5,439 | $34K | 9/2/2026 |
| Adam C. Vandervoort | ▼ Sell | Open Market | 7,573 | $48K | 9/2/2026 |
| Carlos Nueno | ▲ Buy | Option Exercise | 4,556 | — | 9/1/2026 |
| Carlos Nueno | ▲ Buy | Option Exercise | 8,717 | — | 9/1/2026 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 9,152 | — | 9/1/2026 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 426 | — | 9/1/2026 |
| Kelly Bliss | ▲ Buy | Option Exercise | 4,859 | — | 9/1/2026 |
| Kelly Bliss | ▲ Buy | Option Exercise | 9,152 | — | 9/1/2026 |
| Kelly Bliss | ▲ Buy | Option Exercise | 1,300 | — | 9/1/2026 |
| Joseph Ronald Catapano | ▲ Buy | Option Exercise | 833 | — | 9/1/2026 |
| Charles Divita III | ▲ Buy | Option Exercise | 1,966 | — | 9/1/2026 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 5,492 | — | 9/1/2026 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 1,042 | — | 9/1/2026 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 8,717 | — | 9/1/2026 |
| Joseph Ronald Catapano | ▲ Buy | Option Exercise | 39 | — | 9/1/2026 |
| Charles Divita III | ▲ Buy | Option Exercise | 42,277 | — | 9/1/2026 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 5,350 | — | 9/1/2026 |
| Kelly Bliss | ▼ Sell | Open Market | 2,500 | $24K | 7/6/2026 |
| Joseph Ronald Catapano | ▼ Sell | Open Market | 653 | $6K | 7/2/2026 |
| Joseph Ronald Catapano | ▲ Buy | Option Exercise | 2,083 | — | 7/1/2026 |
| Kelly Bliss | ▼ Sell | Open Market | 2,500 | $23K | 7/1/2026 |
| Kelly Bliss | ▼ Sell | Open Market | 2,500 | $21K | 6/29/2026 |
| Charles Divita III | ▼ Sell | Open Market | 18,074 | $125K | 6/11/2026 |
| Charles Divita III | ▲ Buy | Option Exercise | 39,160 | — | 6/10/2026 |
| Charles Divita III | ▲ Buy | Option Exercise | 3,642 | — | 6/10/2026 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 9,572 | $71K | 6/3/2026 |
| Charles Divita III | ▼ Sell | Open Market | 19,132 | $146K | 6/2/2026 |
| Adam C. Vandervoort | ▼ Sell | Open Market | 7,906 | $60K | 6/2/2026 |
| Joseph Ronald Catapano | ▼ Sell | Open Market | 284 | $2K | 6/2/2026 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 5,677 | $43K | 6/2/2026 |
| Carlos Nueno | ▼ Sell | Open Market | 6,196 | $47K | 6/2/2026 |
| Kelly Bliss | ▼ Sell | Open Market | 7,679 | $59K | 6/2/2026 |
| Joseph Ronald Catapano | ▲ Buy | Option Exercise | 39 | — | 6/1/2026 |
| Carlos Nueno | ▲ Buy | Option Exercise | 4,556 | — | 6/1/2026 |
| Kelly Bliss | ▲ Buy | Option Exercise | 9,152 | — | 6/1/2026 |
| Kelly Bliss | ▲ Buy | Option Exercise | 4,858 | — | 6/1/2026 |
| Joseph Ronald Catapano | ▲ Buy | Option Exercise | 833 | — | 6/1/2026 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 5,491 | — | 6/1/2026 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 426 | — | 6/1/2026 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 5,350 | — | 6/1/2026 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 9,152 | — | 6/1/2026 |
| Kelly Bliss | ▲ Buy | Option Exercise | 1,300 | — | 6/1/2026 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 8,716 | — | 6/1/2026 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 1,042 | — | 6/1/2026 |
| Carlos Nueno | ▲ Buy | Option Exercise | 8,716 | — | 6/1/2026 |
| Charles Divita III | ▲ Buy | Option Exercise | 1,966 | — | 6/1/2026 |
| Charles Divita III | ▲ Buy | Option Exercise | 42,276 | — | 6/1/2026 |
| David L. Shedlarz | ▲ Buy | Option Exercise | 29,986 | — | 5/20/2026 |
| Catherine Jacobson | ▲ Buy | Option Exercise | 28,986 | — | 5/20/2026 |
| David B. Snow Jr. | ▲ Buy | Option Exercise | 28,986 | — | 5/20/2026 |
| Joseph Ronald Catapano | ▼ Sell | Open Market | 675 | $3K | 4/2/2026 |
| Joseph Ronald Catapano | ▲ Buy | Option Exercise | 2,083 | — | 4/1/2026 |
| Charles Divita III | ▼ Sell | Open Market | 27,731 | $152K | 3/11/2026 |
| Charles Divita III | ▲ Buy | Option Exercise | 39,160 | — | 3/10/2026 |
| Charles Divita III | ▲ Buy | Option Exercise | 25,493 | — | 3/10/2026 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 25,086 | $125K | 3/3/2026 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 16,314 | $83K | 3/2/2026 |
| Adam C. Vandervoort | ▼ Sell | Open Market | 27,083 | $139K | 3/2/2026 |
| Charles Divita III | ▼ Sell | Open Market | 50,145 | $257K | 3/2/2026 |
| Kelly Bliss | ▼ Sell | Open Market | 26,647 | $136K | 3/2/2026 |
| Carlos Nueno | ▼ Sell | Open Market | 20,165 | $103K | 3/2/2026 |
| Joseph Ronald Catapano | ▼ Sell | Open Market | 1,333 | $7K | 3/2/2026 |
| Carlos Nueno | ▲ Buy | Option Exercise | 4,556 | — | 2/27/2026 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 1,042 | — | 2/27/2026 |
| Carlos Nueno | ▲ Buy | Option Exercise | 3,101 | — | 2/27/2026 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 34,867 | — | 2/27/2026 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 5,491 | — | 2/27/2026 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 4,418 | — | 2/27/2026 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 5,350 | — | 2/27/2026 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 36,610 | — | 2/27/2026 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 1,510 | — | 2/27/2026 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 1,702 | — | 2/27/2026 |
| Charles Divita III | ▲ Buy | Option Exercise | 7,864 | — | 2/27/2026 |
| Kelly Bliss | ▲ Buy | Option Exercise | 4,858 | — | 2/27/2026 |
| Kelly Bliss | ▲ Buy | Option Exercise | 36,610 | — | 2/27/2026 |
| Kelly Bliss | ▲ Buy | Option Exercise | 1,186 | — | 2/27/2026 |
| Kelly Bliss | ▲ Buy | Option Exercise | 5,198 | — | 2/27/2026 |
| Carlos Nueno | ▲ Buy | Option Exercise | 34,867 | — | 2/27/2026 |
| Carlos Nueno | ▲ Buy | Option Exercise | 1,061 | — | 2/27/2026 |
| Joseph Ronald Catapano | ▲ Buy | Option Exercise | 3,333 | — | 2/27/2026 |
| Joseph Ronald Catapano | ▲ Buy | Option Exercise | 155 | — | 2/27/2026 |
| Kelly Bliss | ▲ Buy | Option Exercise | 3,488 | — | 2/27/2026 |
| Joseph Ronald Catapano | ▼ Sell | Open Market | 758 | $5K | 1/5/2026 |
| Joseph Ronald Catapano | ▲ Buy | Option Exercise | 2,083 | — | 1/2/2026 |
| Jason Eric Evans | ▲ Buy | Option Exercise | 1,016 | — | 12/19/2025 |
| Charles Divita III | ▼ Sell | Open Market | 17,138 | $131K | 12/11/2025 |
| Charles Divita III | ▲ Buy | Option Exercise | 39,160 | — | 12/10/2025 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 4,209 | $31K | 12/3/2025 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 2,324 | $17K | 12/2/2025 |
| Adam C. Vandervoort | ▼ Sell | Open Market | 5,720 | $43K | 12/2/2025 |
| Carlos Nueno | ▼ Sell | Open Market | 3,897 | $29K | 12/2/2025 |
| Kelly Bliss | ▼ Sell | Open Market | 4,582 | $34K | 12/2/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 1,505 | — | 12/1/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 4,418 | — | 12/1/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 5,350 | — | 12/1/2025 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 5,491 | — | 12/1/2025 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 1,042 | — | 12/1/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 1,056 | — | 12/1/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 3,101 | — | 12/1/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 4,556 | — | 12/1/2025 |
| Kelly Bliss | ▲ Buy | Option Exercise | 1,189 | — | 12/1/2025 |
| Kelly Bliss | ▲ Buy | Option Exercise | 3,488 | — | 12/1/2025 |
| Kelly Bliss | ▲ Buy | Option Exercise | 4,858 | — | 12/1/2025 |
| Kenneth H. Paulus | ▲ Buy | Open Market | 10,000 | $69K | 11/14/2025 |
| Joseph Ronald Catapano | ▼ Sell | Open Market | 2,972 | $23K | 10/2/2025 |
| Joseph Ronald Catapano | ▲ Buy | Option Exercise | 8,333 | — | 10/1/2025 |
| Jason Eric Evans | ▲ Buy | Option Exercise | 1,016 | — | 9/19/2025 |
| Charles Divita III | ▼ Sell | Open Market | 16,787 | $127K | 9/11/2025 |
| Charles Divita III | ▲ Buy | Option Exercise | 39,160 | — | 9/10/2025 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 4,149 | $31K | 9/3/2025 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 2,383 | $18K | 9/2/2025 |
| Carlos Nueno | ▼ Sell | Open Market | 3,998 | $30K | 9/2/2025 |
| Adam C. Vandervoort | ▼ Sell | Open Market | 5,867 | $45K | 9/2/2025 |
| Kelly Bliss | ▼ Sell | Open Market | 4,700 | $36K | 9/2/2025 |
| Murthy Mala | ▼ Sell | Open Market | 12,846 | $97K | 9/2/2025 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 1,041 | — | 8/29/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 1,056 | — | 8/29/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 4,556 | — | 8/29/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 4,418 | — | 8/29/2025 |
| Kelly Bliss | ▲ Buy | Option Exercise | 3,488 | — | 8/29/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 3,100 | — | 8/29/2025 |
| Kelly Bliss | ▲ Buy | Option Exercise | 1,189 | — | 8/29/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 3,163 | — | 8/29/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 5,350 | — | 8/29/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 1,505 | — | 8/29/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 9,233 | — | 8/29/2025 |
| Kelly Bliss | ▲ Buy | Option Exercise | 4,858 | — | 8/29/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 2,641 | — | 8/29/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 7,751 | — | 8/29/2025 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 5,491 | — | 8/29/2025 |
| Jason Eric Evans | ▲ Buy | Option Exercise | 1,016 | — | 6/20/2025 |
| Charles Divita III | ▲ Buy | Option Exercise | 156,641 | — | 6/10/2025 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 4,174 | $29K | 6/3/2025 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 2,358 | $16K | 6/2/2025 |
| Adam C. Vandervoort | ▼ Sell | Open Market | 5,808 | $40K | 6/2/2025 |
| Carlos Nueno | ▼ Sell | Open Market | 3,958 | $27K | 6/2/2025 |
| Kelly Bliss | ▼ Sell | Open Market | 4,653 | $32K | 6/2/2025 |
| Murthy Mala | ▼ Sell | Open Market | 13,856 | $95K | 6/2/2025 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 1,041 | — | 5/30/2025 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 5,491 | — | 5/30/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 1,505 | — | 5/30/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 4,418 | — | 5/30/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 5,350 | — | 5/30/2025 |
| Kelly Bliss | ▲ Buy | Option Exercise | 1,189 | — | 5/30/2025 |
| Kelly Bliss | ▲ Buy | Option Exercise | 3,488 | — | 5/30/2025 |
| Kelly Bliss | ▲ Buy | Option Exercise | 4,858 | — | 5/30/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 2,641 | — | 5/30/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 2,044 | — | 5/30/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 7,751 | — | 5/30/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 9,233 | — | 5/30/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 3,163 | — | 5/30/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 3,100 | — | 5/30/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 1,056 | — | 5/30/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 4,556 | — | 5/30/2025 |
| MCKINLEY THOMAS | ▲ Buy | Option Exercise | 17,467 | — | 5/21/2025 |
| Catherine Jacobson | ▲ Buy | Option Exercise | 17,467 | — | 5/21/2025 |
| David B. Snow Jr. | ▲ Buy | Grant | 17,467 | — | 5/21/2025 |
| David L. Shedlarz | ▲ Buy | Option Exercise | 17,467 | — | 5/21/2025 |
| Murthy Mala | ▼ Sell | Open Market | 7,494 | $51K | 4/7/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 12,652 | — | 4/4/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 4,418 | — | 3/28/2025 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 2,663 | $21K | 3/21/2025 |
| Adam C. Vandervoort | ▼ Sell | Open Market | 11,011 | $93K | 3/20/2025 |
| Murthy Mala | ▼ Sell | Open Market | 20,586 | $173K | 3/20/2025 |
| Jason Eric Evans | ▲ Buy | Option Exercise | 1,016 | — | 3/20/2025 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 1,503 | $13K | 3/20/2025 |
| Kelly Bliss | ▼ Sell | Open Market | 9,470 | $80K | 3/20/2025 |
| Carlos Nueno | ▼ Sell | Open Market | 8,266 | $70K | 3/20/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 21,400 | — | 3/19/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 36,933 | — | 3/19/2025 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 4,166 | — | 3/19/2025 |
| Kelly Bliss | ▲ Buy | Option Exercise | 19,433 | — | 3/19/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 18,225 | — | 3/19/2025 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 3,558 | $33K | 3/5/2025 |
| Kelly Bliss | ▼ Sell | Open Market | 2,904 | $28K | 3/3/2025 |
| Adam C. Vandervoort | ▼ Sell | Open Market | 3,935 | $38K | 3/3/2025 |
| Fernando M. Rodrigues | ▼ Sell | Open Market | 1,933 | $19K | 3/3/2025 |
| Murthy Mala | ▼ Sell | Open Market | 8,630 | $84K | 3/3/2025 |
| Carlos Nueno | ▼ Sell | Open Market | 2,347 | $23K | 3/3/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 1,881 | — | 2/28/2025 |
| Kelly Bliss | ▲ Buy | Option Exercise | 1,189 | — | 2/28/2025 |
| Adam C. Vandervoort | ▲ Buy | Option Exercise | 1,505 | — | 2/28/2025 |
| Fernando M. Rodrigues | ▲ Buy | Option Exercise | 5,491 | — | 2/28/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 3,369 | — | 2/28/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 2,044 | — | 2/28/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 7,750 | — | 2/28/2025 |
| Murthy Mala | ▲ Buy | Option Exercise | 2,641 | — | 2/28/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 1,123 | — | 2/28/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 3,100 | — | 2/28/2025 |
| Carlos Nueno | ▲ Buy | Option Exercise | 1,056 | — | 2/28/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Teladoc Launches AI-Powered Remote Monitoring Tools
Teladoc Health has introduced new AI features that turn smartphone cameras into vital sign monitors and add ambient care tools to its Solo platform. These updates aim to strengthen the company's competitive position in digital health. While the stock has recently dipped more than the broader market, analysts maintain an average price target of $7.59, suggesting potential value relative to current levels.
Teladoc Launches AI-Powered Remote Monitoring Tools. Teladoc Health has introduced new AI features that turn smartphone cameras into vital sign monitors and add ambient care tools to its Solo platform. These updates aim to strengthen the company's competitive position in digital health. While the stock has recently dipped more than the broader market, analysts maintain an average price target of $7.59, suggesting potential value relative to current levels.